Belgium· BE-AMP-SAM502471-00
Zavicefta 2 g - 0.5 g
A ceftazidim und beta-lactamase-inhibitor product containing avibactam sodium, registered in Belgium by Pfizer Ireland Pharmaceuticals Unlimited Company. The same ATC class is registered in 10 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Ceftazidim und beta-lactamase-inhibitor is registered in 10 of 19 countries.
Countries holding a registration under ATC J01DD52 (ceftazidim und beta-lactamase-inhibitor), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Ceftazidim und beta-lactamase-inhibitor · ATC J01DD52
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of ceftazidim und beta-lactamase-inhibitor costs, country by country.
Normalised to the WHO defined daily dose (6 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ceftazidim und beta-lactamase-inhibitor · price per daily dose (6 g)
USD · FX 28 Sept 2026
- CH Switzerland$407.92
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Avibactam Sodium
- Manufacturer
- Pfizer Ireland Pharmaceuticals Unlimited Company
- Country
- Belgium (BE)
- ATC code
- J01DD52
- ATC class
- Ceftazidim und Beta-Lactamase-Inhibitor
- Defined daily dose
- 6 g, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb3641743
- be_apb7723828
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J01DD52
Ceftazidim und beta-lactamase-inhibitor, as other registers publish it.
- FinlandZaviceftaPfizer Ireland Pharmaceuticals Unlimited Company
- IcelandZaviceftaPfizer Ireland Pharmaceuticals
- FinlandZaviceftaOrifarm Oy
- DenmarkZaviceftaPfizer Ireland Pharmaceuticals
- PolandZaviceftaPfizer Ireland Pharmaceuticals
- NorwayZaviceftaPfizer Ireland Pharmaceuticals Unlimited Company
- CzechiaZAVICEFTAPfizer Ireland Pharmaceuticals Unlimited Company, Ringaskiddy
- NetherlandsZAVICEFTA 2 g/0,5 g, poeder voor concentraat voor oplossing voor infusiePfizer Ireland Pharmaceuticals, Operations Services Group
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/efa584ea-1eb0-474f-9113-ed2a4bd46b6f GET /v1/drugs/efa584ea-1eb0-474f-9113-ed2a4bd46b6f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for concentrate for solution for infusion",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Zavicefta 2 g - 0.5 g",
"name_fr": "Zavicefta 2 g - 0.5 g",
"name_nl": "Zavicefta 2 g - 0.5 g",
"amp_code": "SAM502471-00",
"strengths": [
"0.5000",
"0.5000",
"2.0000",
"2.0000",
"148.0000"
],
"pack_count": 1,
"substances": [
"Avibactam Sodium",
"Avibactam",
"Ceftazidime Pentahydrate",
"Ceftazidime",
"Sodium"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Ceftazidime and Beta-Lactamase Inhibitor",
"authorisation_numbers": [
"EU/1/16/1109/001"
]
}See everything about ceftazidim und beta-lactamase-inhibitor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.